JCI - Citations to Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

Citations to this article

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

M Kornmann, … , N Arber, M Korc

M Kornmann, … , N Arber, M Korc

Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):344-352. https://doi.org/10.1172/JCI1323.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2024	2022	2021	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	Total
Citations:	1	1	1	1	3	1	1	1	9	3	1	3	5	6	5	4	3	5	11	15	8	7	7	1	103

Citation information

Citations to this article (103)

Title and authors	Publication	Year
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review Salahi\u2010Niri A, Zarand P, Mansouri N, Rastgou P, Yazdani O, Esbati R, Shojaeian F, Jahanbin B, Mohsenifar Z, Aghdaei HA, Ardalan FA, Safavi\u2010Naini SA	Health Science Reports	2025
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis Sigafoos AN, Tolosa EJ, Carr RM, Fernandez-Barrena MG, Almada LL, Pease DR, Hogenson TL, Raja Arul GL, Mousavi F, Sen S, Vera RE, Marks DL, Flores LF, LaRue-Nolan KC, Wu C, Bamlet WR, Vrabel AM, Sicotte H, Schenk EL, Smyrk TC, Zhang L, Rabe KG, Oberg AL, Zaphiropoulos PG, Chevet E, Graham RP, Hagen CE, di Magliano MP, Elsawa SF, Pin CL, Mao J, McWilliams RR, Fernandez-Zapico ME	Cancer research communications	2024
Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma. Rudloff U	Expert Opinion on Emerging Drugs	2022
N , N -Ru( ii )- p -cymene-poly( N -vinylpyrrolidone) surface functionalized gold nanoparticles: from organoruthenium complex to nanomaterial for antiproliferative activity D Gopalakrishnan, S Saravanan, R Merckx, AM Kumar, T Khamrang, M Velusamy, K Vasanth, S Sunitha, R Hoogenboom, S Maji, M Ganeshpandian	Dalton Transactions	2021
Expression of Rab5a correlates with tumor progression in pancreatic carcinoma Y Li, X Sun, D Ji, X Kong, D Liu, Z Zhao, J Yan, S Chen	Virchows Archiv	2017
Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo B Traub, L Sun, Y Ma, P Xu, J Lemke, S Paschke, D Henne-Bruns, U Knippschild, M Kornmann	International journal of molecular sciences	2017
Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells Z He, X Xiao, S Li, Y Guo, Q Huang, X Shi, X Wang, Y Liu	Oncology Letters	2017
Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer L Yu, X Li, H Li, H Chen, H Liu	Tumor Biology	2016
NF-κB in cancer therapy F Li, J Zhang, F Arfuso, A Chinnathambi, ME Zayed, SA Alharbi, AP Kumar, KS Ahn, G Sethi	Archives of Toxicology	2015
Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing S Iizuka, N Oridate, M Nashimoto, S Fukuda, M Tamura, MT Teh	PloS one	2014
Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer R Takahashi, Y Hirata, K Sakitani, W Nakata, H Kinoshita, Y Hayakawa, H Nakagawa, K Sakamoto, Y Hikiba, H Ijichi, HL Moses, S Maeda, K Koike	Cancer Science	2013
Inhibition of Pancreatic Cancer Cell Growth In Vivo Using a Tetracycline-Inducible Cyclin D1 Antisense Expression System: JC Wang, M Thiere, D Henne-Bruns, U Knippschild, M Kornmann	Pancreas	2013
Targeted Delivery of Dendritic Polyglycerol–Doxorubicin Conjugates by scFv-SNAP Fusion Protein Suppresses EGFR + Cancer Cell Growth AF Hussain, HR Krüger, F Kampmeier, T Weissbach, K Licha, F Kratz, R Haag, M Calderón, S Barth	Biomacromolecules	2013
IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination MM Chitnis, KA Lodhia, T Aleksic, S Gao, AS Protheroe, VM Macaulay	Oncogene	2013
Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation LH Yan, XT Wang, J Yang, C Lian, FB Kong, WY Wei, W Luo, Q Xiao, YB Xie	World journal of gastroenterology : WJG	2013
Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma Y Guo, K Yan, J Fang, Q Qu, M Zhou, F Chen	Journal of Experimental & Clinical Cancer Research	2013
Reversal of Multidrug Resistance in Gastric Cancer Cells by E2F-1 Downregulation In Vitro and In Vivo: E2F-1 Downregulation in Gastric Cancer Cells LH Yan, XT Wang, J Yang, FB Kong, C Lian, WY Wei, W Luo, YB Xie, Q Xiao	Journal of Cellular Biochemistry	2013
Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil JH Seo, ES Jeong, KS Lee, SH Heo, DG Jeong, YK Choi	International journal of oncology	2013
Cancer Chemoprevention and Treatment by Diet Therapy WC Cho		2013
Current Knowledge on Pancreatic Cancer J Iovanna, MC Mallmann, A Gonçalves, O Turrini, JC Dagorn	Frontiers in Oncology	2012
Mechanism of the antitumoral activity of Deferasirox, an iron chelation agent, on mantle cell lymphoma L Vazana-Barad, G Granot, R Mor-Tzuntz, I Levi, M Dreyling, I Nathan, O Shpilberg	Leukemia & Lymphoma	2012
Coffee Polyphenols Change the Expression of STAT5B and ATF-2 Modifying Cyclin D1 Levels in Cancer Cells C Oleaga, CJ Ciudad, V Noé, M Izquierdo-Pulido	Oxidative medicine and cellular longevity	2012
Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells JY Wang, Q Wang, Y Cui, ZY Liu, W Zhao, CL Wang, Y Dong, LJ Hou, GH Hu, C Luo, J Chen, YC Lu	Journal of Neuro-Oncology	2011
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers EE Noel, M Yeste-Velasco, X Mao, J Perry, SC Kudahetti, NF Li, S Sharp, T Chaplin, L Xue, A McIntyre, L Shan, T Powles, RT Oliver, BD Young, J Shipley, DM Berney, SP Joel, YJ Lu	The American Journal of Pathology	2010
Pancreatic cancer: gene therapy approaches and gene delivery systems J Xu, C Jin, S Hao, G Luo, D Fu	Expert Opinion on Biological Therapy	2010
MUC1 regulates nuclear localization and function of the epidermal growth factor receptor BG Bitler, A Goverdhan, JA Schroeder	Journal of cell science	2010
Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion T Layton, C Stalens, F Gunderson, S Goodison, S Silletti	The American Journal of Pathology	2009
Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth SJ Deharvengt, JR Gunn, SB Pickett, M Korc	Cancer Gene Therapy	2009
Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and differentiation B Uzan, F Figeac, B Portha, J Movassat	PloS one	2009
Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity X Zhou, Z Zhang, X Yang, W Chen, P Zhang	International Journal of Cancer	2009
Mechanisms of KGF Mediated Signaling in Pancreatic Duct Cell Proliferation and Differentiation B Uzan, F Figeac, B Portha, J Movassat, K Maedler	PloS one	2009
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite O Hemmingsson, Y Zhang, M Still, P Naredi	Cancer Chemotherapy and Pharmacology	2008
A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells S Wei, HC Yang, HC Chuang, J Yang, SK Kulp, PJ Lu, MD Lai, CS Chen	The Journal of biological chemistry	2008
Exon III Splicing of Fibroblast Growth Factor Receptor 1 Is Modulated by Growth Factors and Cyclin D1 G Chen, J Wang, Z Liu, M Kornmann	Pancreas	2008
A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells S Wei, HC Yang, HC Chuang, J Yang, SK Kulp, PJ Lu, MD Lai, CS Chen	The Journal of biological chemistry	2008
Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level H Kim, C Jo, BG Jang, U Oh, SA Jo	Cellular Signalling	2008
EGFR Signaling Networks in Cancer Therapy JD Haley, WJ Gullick		2008
Glypican-1 Modulates the Angiogenic and Metastatic Potential of Cancer Cells Takuma Aikawa, Chery Whipple, Martha E. Lopez, Jason Gunn, Alison Young, Arthur D. Lander and Murray Korc	Journal of Clinical Investigation	2007
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression E Tashiro, A Tsuchiya, M Imoto	Cancer Science	2007
Cell-specific responses to loss of cyclin-dependent kinases C Berthet, P Kaldis	Oncogene	2007
Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy E Higuchi, N Oridate, A Homma, F Suzuki, Y Atago, T Nagahashi, Y Furuta, S Fukuda	Head & Neck	2007
Expression of nuclear notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt H Doucas, CD Mann, CD Sutton, G Garcea, CP Neal, DP Berry, MM Manson	Journal of Surgical Oncology	2007
Pancreatic cancer: pathogenesis, prevention and treatment FH Sarkar, S Banerjee, Y Li	Toxicology and Applied Pharmacology	2006
Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma M Rieber, MS Rieber	Apoptosis	2006
Chemoprevention of pancreatic cancer: A review of the molecular pathways involved, and evidence for the potential for chemoprevention H Doucas, G Garcea, CP Neal, MM Manson, DP Berry	Pancreatology	2006
Development of Small-Molecule Cyclin D1-Ablative Agents JW Huang, CW Shiau, J Yang, DS Wang, HC Chiu, CY Chen, CS Chen	Journal of Medicinal Chemistry	2006
Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance H Doucas, G Garcea, CP Neal, MM Manson, DP Berry	European Journal of Cancer	2005
Pancreatic intra-epithelial neoplasia: current clinicopathological and molecular considerations AA Andea, O Basturk, NV Adsay	Current Diagnostic Pathology	2005
Cyclin D1 in Breast Cancer Pathogenesis A Arnold, A Papanikolaou	Journal of Clinical Oncology	2005
Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells K Kisfalvi, S Guha, E Rozengurt	Journal of Cellular Physiology	2004
Small antisense RNA to cyclin D1 generated by pre-tRNA splicing inhibits growth of human hepatoma cells D Lai, S Weng, C Wang, L Qi, C Yu, L Fu, W Chen	FEBS Letters	2004
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines: L Zhang, SE Plon, JG Nuchtern, S Burlingame, S Blaney, R Rousseau, S Berg	Anti-Cancer Drugs	2004
14-3-3σ Mediation of Cell Cycle Progression Is p53-independent in Response to Insulin-like Growth Factor-I Receptor Activation Y Zhang, M Karas, H Zhao, S Yakar, D LeRoith	The Journal of biological chemistry	2004
Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK H Zhu, L Zhang, S Wu, F Teraishi, JJ Davis, D Jacob, B Fang	Oncogene	2004
Oncogenic transformation of normal enterocytes by overexpression of cyclin D1 D Kazanov, I Shapira, M Pick, O Kolker, E Liberman, V Deutsch, L Strier, H Dvory-Sobol, T Kunik, N Arber	Digestive Diseases and Sciences	2003
Pathways for aberrant angiogenesis in pancreatic cancer M Korc	Molecular Cancer	2003
Over-expression of cyclin D1 regulates Cdk4 protein synthesis MA Parker, NG Deane, EA Thompson, RH Whitehead, SK Mithani, MK Washington, PK Datta, DA Dixon, RD Beauchamp	Cell Proliferation	2003
Intracellular redistribution of protein kinase D2 in response to G-protein-coupled receptor agonists O Rey, J Yuan, E Rozengurt	Biochemical and Biophysical Research Communications	2003
Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells Q Liao, J Guo, J Kleeff, A Zimmermann, MW Büchler, M Korc, H Friess	Gastroenterology	2003
Dual Mechanisms for Lysophosphatidic Acid Stimulation of Human Ovarian Carcinoma Cells YL Hu, C Albanese, RG Pestell, RB Jaffe	JNCI Journal of the National Cancer Institute	2003
Protein Kinase Cν/Protein Kinase D3 Nuclear Localization, Catalytic Activation, and Intracellular Redistribution in Response to G Protein-coupled Receptor Agonists O Rey, J Yuan, SH Young, E Rozengurt	The Journal of biological chemistry	2003
Small-molecule cyclin-dependent kinase modulators AM Senderowicz	Oncogene	2003
Chemosensitivity Testing in Oncology U Reinhold, W Tilgen		2003
Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer A Ryo, YC Liou, KP Lu, G Wulf	Journal of cell science	2003
Over-expression of cyclin D1 regulates Cdk4 protein synthesis: Cdk4 protein synthesis MA Parker, NG Deane, EA Thompson, RH Whitehead, SK Mithani, MK Washington, PK Datta, DA Dixon, RD Beauchamp	Cell Proliferation	2003
Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells T Seufferlein, MJ Seckl, E Schwarz, M Beil, G Wichert, H Baust, H Lührs, RM Schmid, G Adler	British Journal of Cancer	2002
Targeting the cell cycle for cancer therapy A Carnero	British Journal of Cancer	2002
p53 Inhibits Adriamycin-Induced Down-Regulation of Cyclin D1 Expression in Human Cancer Cells J Shao, F Teraishi, K Katsuda, N Tanaka, T Fujiwara	Biochemical and Biophysical Research Communications	2002
Head and neck cancer: gene therapy approaches.Part II: genes delivered J O’Brien, J Nemunaitis	Expert Opinion on Biological Therapy	2002
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas L Milas, T Akimoto, NR Hunter, KA Mason, L Buchmiller, M Yamakawa, H Muramatsu, KK Ang	International journal of radiation oncology, biology, physics	2002
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells K Hashimoto, RT Ethridge, BM Evers	International Journal of Gastrointestinal Cancer	2002
IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells M Kornmann, T Ishiwata, K Matsuda, ME Lopez, K Fukahi, G Asano, HG Beger, M Korc	Gastroenterology	2002
STAT3 Down-regulates the Expression of Cyclin D during Liver Development T Matsui, T Kinoshita, T Hirano, T Yokota, A Miyajima	The Journal of biological chemistry	2002
Targeting the cell cycle for cancer therapy A Carnero	British Journal of Cancer	2002
p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma ER Sauter, R Takemoto, S Litwin, M Herlyn	Cancer Gene Therapy	2002
Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells MA Stull, MM Richert, AV Loladze, TL Wood	Endocrinology	2002
PIN1 Is an E2F Target Gene Essential for Neu / Ras -Induced Transformation of Mammary Epithelial Cells A Ryo, YC Liou, G Wulf, M Nakamura, SW Lee, KP Lu	Molecular and cellular biology	2002
Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians H Darwish, IE Trejo, I Shapira, S Oweineh, M Sughayer, L Baron, E Aljadeff, M Silbermann, W Sweidan, D Zilberg, Z Halpern, H Hibshoosh, N Arber	Annals of Oncology	2002
Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1 J Hanai, M Dhanabal, SA Karumanchi, C Albanese, M Waterman, B Chan, R Ramchandran, R Pestell, VP Sukhatme	The Journal of biological chemistry	2002
Novel Protein Kinases in Pancreatic Cell Growth and Cancer T Seufferlein	International Journal of Gastrointestinal Cancer	2002
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically activein vitro and enhances tumorigenicityin vivo J Luo, P Guo, K Matsuda, N Truong, A Lee, C Chun, SY Cheng, M Korc	International Journal of Cancer	2001
Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 GM Wulf, A Ryo, GG Wulf, SW Lee, T Niu, V Petkova, KP Lu	The EMBO Journal	2001
Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells ME Laurance, DB Starr, EF Michelotti, E Cheung, C Gonzalez, AW Tam, J Deikman, CA Edwards, AJ Bardwell	Nucleic Acids Research	2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours M Gugger, A Kappeler, S Vonlanthen, HJ Altermatt, HB Ris, D Lardinois, MM Borner, J Heighway, DC Betticher	Lung Cancer	2001
Antisense Cyclin D1 Inhibits Growth of Head and Neck Cancer Xenografts in Nude Mice SJ Wang, LE Mintz, V Natarajan, NJ Lee, ES Srivatsan, MB Wang	Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery	2001
Antisense Cyclin D1 Enhances Sensitivity of Head and Neck Cancer Cells to Cisplatin: MB Wang, HT Yip, ES Srivatsan	The Laryngoscope	2001
Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells M Kornmann, ME Lopez, HG Beger, M Korc	International Journal of Gastrointestinal Cancer	2001
Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells. Saikawa Y, Kubota T, Otani Y, Kitajima M, Modlin IM	Japanese journal of cancer research : Gann	2001
Fas and Fas-ligand expression in human pancreatic cancer M Kornmann, T Ishiwata, J Kleeff, HG Beger, M Korc	Annals of Surgery	2000
Fas and Fas-Ligand Expression in Human Pancreatic Cancer M Kornmann, T Ishiwata, J Kleeff, HG Beger, M Korc	Annals of Surgery	2000
Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes P Capaccio, G Pruneri, N Carboni, AV Pagliari, M Quatela, BM Cesana, L Pignataro	Head & Neck	2000
New role for tRNA and its fragment purified from human urinary bladder carcinoma conditioned medium: Inhibition of endothelial cell growth H Zhao, K Bojanowski, DE Ingber, D Panigrahy, MS Pepper, R Montesano, Y Shing	Journal of Cellular Biochemistry	2000
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells J Kleeff, M Kornmann, H Sawhney, M Korc	International Journal of Cancer	2000
GROWTH FACTORS, RECEPTORS, AND MOLECULAR ALTERATIONS IN PANCREATIC CANCER CD Ulrich	Medical Clinics of North America	2000
Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1 A Tan, P Bitterman, N Sonenberg, M Peterson, V Polunovsky	Oncogene	2000
Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo J Kleeff, H Maruyama, T Ishiwata, H Sawhney, H Friess, MW Büchler, M Korc	Gastroenterology	1999
Smad6 Suppresses TGF-β-Induced Growth Inhibition in COLO-357 Pancreatic Cancer Cells and Is Overexpressed in Pancreatic Cancer J Kleeff, H Maruyama, H Friess, MW Büchler, D Falb, M Korc	Biochemical and Biophysical Research Communications	1999
TGF-?-1 up-regulates cyclin D1 expression in colo-357 cells, whereas suppression of cyclin d1 levels is associated with down-regulation of the type I TGF-? receptor M Kornmann, P Tangvoranuntakul, M Korc	International Journal of Cancer	1999
CDK inhibition and cancer therapy MD Garrett, A Fattaey	Current Opinion in Genetics & Development	1999
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer J Kleeff, T Ishiwata, H Maruyama, H Friess, P Truong, MW Büchler, D Falb, M Korc	Oncogene	1999
Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis B Driscoll, S Buckley, L Barsky, K Weinberg, KD Anderson, D Warburton	American journal of physiology. Lung cellular and molecular physiology	1999
A role for intracellular immunization in chemosensitization of tumor cells? A Piché, C Rancourt	Gene Therapy	1999
Molecular Cloning and Characterization of TIEG2 Reveals a New Subfamily of Transforming Growth Factor-β-inducible Sp1-like Zinc Finger-encoding Genes Involved in the Regulation of Cell Growth T Cook, B Gebelein, K Mesa, A Mladek, R Urrutia	The Journal of biological chemistry	1998

Advertisement